|Bid||13,550.00 x 0|
|Ask||13,669.00 x 0|
|Day's Range||13,450.00 - 13,808.00|
|52 Week Range||7,874.00 - 17,136.60|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||162.16|
|Forward Dividend & Yield||105.00 (0.78%)|
|Ex-Dividend Date||Aug. 04, 2020|
|1y Target Est||20,275.00|
VANCOUVER, BC, July 10, 2020 /CNW/ - A number of emissions class actions were commenced across Canada concerning 2009-2016 Volkswagen, Audi and Porsche vehicles equipped with diesel engines (the "Emissions Claims"). A separate action against Robert Bosch GmbH (the "Bosch Action") has been certified and is now the subject of a proposed settlement. The certification and settlement of the Bosch Action affects the rights of Bosch Settlement Class Members.
BIRMINGHAM, Ala. and STUTTGART, Germany , May 26, 2020 /CNW/ -- BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch Vivalytic all-in-one ...
WAIBLINGEN, Germany, March 26, 2020 /CNW/ -- Bosch Healthcare Solutions is currently working on the development of a COVID-19 rapid testing kit for the Vivalytic platform and will launch this in April 2020. The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient's sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as nine other possible viral respiratory diseases. With the Vivalytic VRI test, physicians can quickly and efficiently distinguish between different infections with very similar symptoms, like influenza, and immediately begin the appropriate treatment.